Compounds > ciprofloxacin

ciprofloxacin and serine

ciprofloxacin has been researched along with serine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, LM; Peterson, LR; Sreedharan, S1
Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M1
Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S1
Kiang, JG; Smith, JT; Swift, JM1
Ramana, J1

Other Studies

5 other study(ies) available for ciprofloxacin and serine

ArticleYear
Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:10

    Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; Coagulase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Serine; Staphylococcus aureus; Staphylococcus epidermidis

1991
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Journal of clinical microbiology, 1997, Volume: 35, Issue:9

    Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections

1997
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    The Journal of urology, 2000, Volume: 164, Issue:3 Pt 1

    Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine

2000
Ciprofloxacin Therapy Results in Mitigation of ATP Loss after Irradiation Combined with Wound Trauma: Preservation of Pyruvate Dehydrogenase and Inhibition of Pyruvate Dehydrogenase Kinase 1.
    Radiation research, 2015, Volume: 183, Issue:6

    Topics: Adenosine Triphosphate; Administration, Oral; Animals; Ciprofloxacin; Female; Gamma Rays; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Ileum; Mice; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex; Radiation Injuries, Experimental; Serine; Wounds and Injuries

2015
Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:5

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aspartic Acid; Binding Sites; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gene Expression; Kinetics; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Norfloxacin; Protein Binding; Serine; Shigella flexneri; Thermodynamics

2016